Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitraClip in Moderate Functional Mitral Regurgitation
NCT03891823Terminated
- Sponsor
- Montréal Heart Institute
- Start
- Mar 2019
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in functional mitral regurgitation (FMR) and heart failure (HF) (2 arms), sponsored by Montréal Heart Institute. Primary endpoint: Change In Mitral Regurgitation at 24 months. Started Mar 2019; status: terminated.
02
Conditions
functional mitral regurgitation (FMR)heart failure (HF)
Beyond the preview
Go deeper on NCT03891823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03891823.